Institutional Ownership
Citius Pharmaceuticals Inc
CUSIP 17322U306COMCTXRQ1 2026
13D / 13G Filings
3
Schedule 13D/13G on record
Beneficial Filers
2
Distinct reporting persons
Largest Stake
9.9%
Max % of class reported
Institutional Holders
34
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
3 filings · latest Feb 17, 2026
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 246.2K | $221.6K |
| 2 | Blackrock, Inc. | 69.9K | $62.9K |
| 3 | Asset Advisory Group, Inc. | 59.0K | $53.1K |
| 4 | Ubs Group AG | 55.0K | $49.5K |
| 5 | Northern Trust Corp | 44.0K | $39.6K |
| 6 | Susquehanna International Group, LLP | 36.8K | $33.2K |
| 7 | Lpl Financial LLC | 25.0K | $22.5K |
| 8 | State Street Corp | 23.3K | $20.9K |
| 9 | Jane Street Group, LLC | 22.5K | $20.3K |
| 10 | Xtx Topco Ltd | 21.3K | $19.2K |